moxifloxacin has been researched along with Tuberculosis, Meningeal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alffenaar, JW; de Vries, PM; Luijckx, GJ; van Altena, R; van der Werf, TS; van Soolingen, D | 1 |
| Carrera-Pineda, R; Garcia-Luna, RC; Soto-Cabrera, E; Villamil-Osorio, LV | 1 |
| Aarnoutse, R; Burger, D; Dian, S; Donders, R; Ganiem, AR; Ruesen, C; Ruslami, R; Te Brake, L; van Crevel, R | 1 |
| Aarnoutse, RE; Alffenaar, JW; Bökkerink, HJ; Luijckx, GJ; van Altena, R; van der Werf, TS; van Soolingen, D | 1 |
| Alffenaar, JW; Greijdanus, B; Pranger, AD; Uges, DR; Wessels, AM | 1 |
| Brouwer, MC; van de Beek, D | 1 |
| Aarnoutse, RE; Achmad, TH; Apriani, L; Borm, G; Dian, S; Ganiem, AR; Ruslami, R; van Crevel, R; van der Ven, AJ | 1 |
2 trial(s) available for moxifloxacin and Tuberculosis, Meningeal
| Article | Year |
|---|---|
Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis.
Topics: Adolescent; Adult; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Indonesia; Male; Middle Aged; Moxifloxacin; Plasma; Rifampin; Survival Analysis; Tuberculosis, Meningeal; Young Adult | 2015 |
Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
Topics: Adolescent; Adult; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Humans; Indonesia; Male; Middle Aged; Moxifloxacin; Quinolines; Rifampin; Tuberculosis, Meningeal; Young Adult | 2013 |
5 other study(ies) available for moxifloxacin and Tuberculosis, Meningeal
| Article | Year |
|---|---|
Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Drug Monitoring; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Tuberculosis, Meningeal | 2008 |
[Optochiasmatic tuberculomas as a paradoxical reaction to treatment for meningeal tuberculosis].
Topics: Adult; Antitubercular Agents; Brain Infarction; Diagnostic Errors; Disease Progression; Drug Resistance, Microbial; Drug Substitution; Ethambutol; Female; Host-Pathogen Interactions; Humans; Isoniazid; Magnetic Resonance Imaging; Meningitis, Viral; Moxifloxacin; Mycobacterium tuberculosis; Neuroimaging; Optic Chiasm; Paresis; Prednisone; Pyrazinamide; Rifampin; Thalamus; Tuberculoma; Tuberculosis, Meningeal; Vision Disorders | 2018 |
Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis.
Topics: Adult; Aged; Antitubercular Agents; Area Under Curve; Aza Compounds; Cerebrospinal Fluid; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Plasma; Quinolines; Time Factors; Tuberculosis, Meningeal | 2009 |
Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography- tandem mass spectrometry method.
Topics: Antitubercular Agents; Area Under Curve; Aza Compounds; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Fluoroquinolones; Humans; Imipramine; Moxifloxacin; Quinolines; Reproducibility of Results; Tandem Mass Spectrometry; Tuberculosis, Meningeal; Ultrafiltration | 2010 |
Intensified intravenous rifampicin in tuberculous meningitis.
Topics: Antitubercular Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Rifampin; Tuberculosis, Meningeal | 2013 |